XML 74 R50.htm IDEA: XBRL DOCUMENT v3.25.1
Issued share capital, share premium account and share options (Tables)
12 Months Ended
Mar. 31, 2025
Issued share capital, share premium account and share options  
Schedule of share capital

At March 31, 

    

2025

    

2024

    

2023

 

€M

 

€M

 

€M

Authorized/Share Capital reorganization

1,550,000,000 ordinary equity shares of 0.600 euro cent each

 

9.3

 

9.3

 

9.3

1,368,000,000 'B' Shares of 0.050 euro cent each

 

0.7

 

0.7

 

0.7

1,368,000,000 Deferred shares of 0.050 euro cent each

 

0.7

 

0.7

 

0.7

 

10.7

 

10.7

10.7

Allotted, called-up and partly paid:

1,138,674,528 ordinary equity shares of 0.600 euro cent each

 

 

 

6.9

1,140,045,528 ordinary equity shares of 0.600 euro cent each

6.9

1,063,868,001 ordinary equity shares of 0.600 euro cent each

6.4

6.4

 

6.9

6.9

Schedule of share premium account

At March 31, 

    

2025

    

2024

    

2023

 

€M

 

€M

 

€M

Balance at beginning of year

 

1,404.3

 

1,379.9

 

1,328.2

Net proceeds from shares issued

4.9

16.4

31.7

Share premium receivable on shares issued

12.4

8.0

20.0

Balance at end of year

 

1,421.6

 

1,404.3

 

1,379.9

Schedule of share options outstanding

Share

Weighted Avg.

    

Options

    

Exercise

     

M

     

Price (€)

Outstanding at March 31, 2022

 

22.8

10.57

Granted

 

Forfeited

Exercised

 

(4.1)

7.64

Outstanding at March 31, 2023

 

18.7

11.24

Granted

Forfeited

(0.7)

11.12

Exercised

(1.4)

12.00

Outstanding at March 31, 2024

 

16.6

11.18

Granted

Forfeited

Exercised

(0.4)

11.45

Outstanding at March 31, 2025

 

16.2

11.12

Schedule of range of exercise prices and weighted average remaining contractual life

No.

Remaining

Exercise

options

contractual

price

outstanding

life

M

     

(years)

Unvested

11.12

16.0

3.9

Vested

11.12

0.2

0.9

Weighted average

11.12

16.2

3.9